KETAMINE INFUSIONS: PHARMACOKINETICS AND CLINICAL EFFECTS

Open Access
Publisher Website
Google Scholar
Abstract
The clinical effects and pharmacokinetics of ketamine, administered as an i.v. infusion, were studied in 31 patients. Anaesthesia was induced with ketamine 2 mg kg−1 i.v. and maintained using an i.v. infusion of ketamine, supplemented by nitrous oxide. The plasma concentrations of ketamine, nor-ketamine and dehydro-nor-ketamine were analysed using gas-liquid chromatography. The average maintenance dose of ketamine was 41 ± 21 μg kg−1 min−1, but there was an obvious decrease in the dose required as anaesthesia progressed. This dose gave a stable plasma concentration of ketamine of 9.3 ± 0.8 μmol litre−1. Patients recovered at 2.7 ± 0.9 μmol litre−1. Plasma half-life of ketamine was 79 ±8 min. Maximum concentration of nor-ketamine was 4.7 ± 2.4 μmol litre−1 and of dehydro-nor-ketamine 3.2 ± 1.9 μmol litre−1. There were transient increases (15–30% of pre anaesthetic values) in arterial pressure, heart rate and cardiac output during operation. No postoperative respiratory depression was seen.

This publication has 1 reference indexed in Scilit: